137 related articles for article (PubMed ID: 8361116)
1. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility].
Mineshita M; Miyazawa T; Doi M; Suei S; Matsuura M; Senoo T; Yamakido M
Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis].
Xia XX
Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing].
Tsukamura M
Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008
[TBL] [Abstract][Full Text] [Related]
4. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
5. [Clinical studies on lung disease due to atypical mycobacteria in our hospital during the past 13 years].
Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Kobayashi T; Koumo T; Uenoyama T; Moriya O; Nishimoto M
Kekkaku; 1991 Sep; 66(9):599-603. PubMed ID: 1942731
[TBL] [Abstract][Full Text] [Related]
6. [Resistance behavior of atypical mycobacteria to antibiotics and sulfonamides].
Neubert R
Z Erkr Atmungsorgane; 1986; 167(1-2):47-51. PubMed ID: 3765715
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacterial disease of the lungs in Singapore.
Teo SK; Lo KL
Singapore Med J; 1992 Oct; 33(5):464-6. PubMed ID: 1455269
[TBL] [Abstract][Full Text] [Related]
8. Photochromogenic and scotochromogenic mycobacteria: their clinical significance.
Gimpl F
Acta Microbiol Acad Sci Hung; 1979; 26(3):185-92. PubMed ID: 543456
[TBL] [Abstract][Full Text] [Related]
9. [Present status of pulmonary atypical mycobacteriosis in community general hospitals].
Yoshino K; Kusajima K; Ohishi F; Shimoide H; Murata Y; Sato N
Kekkaku; 1989 Dec; 64(12):747-52. PubMed ID: 2615129
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of pulmonary disease due to Mycobacterium avium and M. intracellulare identified by a newly developed DNA probe (Gen-Probe].
Mizutani S
Kekkaku; 1991 Jan; 66(1):19-38. PubMed ID: 2013966
[TBL] [Abstract][Full Text] [Related]
11. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
Imwidthaya P; Komolpis P; Suthiravitayavaniz K; Rienthong S
J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
[TBL] [Abstract][Full Text] [Related]
12. [The comparison of drug susceptibility of antituberculous agents against colonizing M. intracellulare and infectious M. intracellulare].
Maesaki S; Higashiyama Y; Mitsutake K; Matsuda H; Yamada H; Sugiyama H; Kaku M; Koga H; Kohno S; Hara K
Kekkaku; 1991 Jul; 66(7):503-5. PubMed ID: 1890793
[TBL] [Abstract][Full Text] [Related]
13. [Effectiveness of the combined therapy of pulmonary mycobacterial infections depending on the species classification of the causative agent].
Kochetov BI; Deviatova AI
Ter Arkh; 1987; 59(7):80-2. PubMed ID: 3118493
[TBL] [Abstract][Full Text] [Related]
14. [A case of pulmonary disease due to Mycobacterium avium-intracellulare complex].
Kuwabara M; Kato M; Kim SK; Kiyotani K; Tasaka H
Kekkaku; 1977 Apr; 52(4):189-92. PubMed ID: 881756
[No Abstract] [Full Text] [Related]
15. [Investigation of the cases due to Mycobacterium kansasii in our hospital].
Sasaki Y; Yamagishi F; Suzuki K; Mori N; Yagi T; Ihara S
Kekkaku; 1992 May; 67(5):377-81. PubMed ID: 1597935
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
Zhao T; Yang SR
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
[No Abstract] [Full Text] [Related]
17. The diagnosis and management of disease caused by M. avium complex, M. kansasii, and other mycobacteria.
Davidson PT
Clin Chest Med; 1989 Sep; 10(3):431-43. PubMed ID: 2673651
[TBL] [Abstract][Full Text] [Related]
18. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
Truffot-Pernot C; Giroir AM; Maury L; Grosset J
Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
[TBL] [Abstract][Full Text] [Related]
20. [Studies on epidemiology of nontuberculous mycobacteriosis--on the regional difference of the incidence of pulmonary diseases due to M. kansasii and M. avium complex in Tokyo area].
Shimoide H; Fukui T; Anzai E; Mizutani S
Kekkaku; 1991 Oct; 66(10):671-7. PubMed ID: 1960915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
